Abstract:Objective:To investigate the mechanism behind campotothecin (CPT) enhancement of TRAIL-induced apoptosis of PANC-1 pancreatic carcinoma cell line.Methods:The growth inhibition rates of PANC-1 cells in the TRAIL, CPT and CPT+TRAIL groups were assayed by MTT Cellular apoptosis in each group was tested by fluorescent staining with Hoechst 33258.The level of apoptotic signal transduction proteins,such as Caspase-8,Caspase-3,DR4,DR5 and c-Flip,were detected using Western blot.Results:Twenty-four hours after PANC-1 cells were treated with TRAIL of various concentrations (10,30,100,300,and 1000 ng/mL),there were significant differences between the treatment and control groups at 100ng/ml and higher (P0.01).Despite these differences,the inhibition rate was only 10.60 ± 2.36% with a TRAIL concentration of 1000ng/mL.There were significant differences between the TRAIL+CPT combination group (10,30, 100,300,1000 ng/mL) and the CPT alone group (P0.05).Results of Hoechst 33258 fluorescent staining showed that typical characteristics of apoptosis such as nucleus aggregation,marginalization and nuclear fragmentation occurred in the TRAIL+CPT group.However,no obvious signs of apoptosis were seen in the groups treated only with TRAIL.Western blot results showed that pro-caspase-8 and pro-caspase-3 could only be seen in the groups treated with TRAIL or CPT alone. However,bands for both the precursors and the cleaved products were seen in the groups treated with both drugs.In addition, the expression of c-Flip protein in PANC-1 cells was down-regulated after CPT treatment.There were significant differences in the expression of c-Flip protein between the CPT and combination treatment group and the groups treated with TRAIL alone and the control groups.There were no significant differences in the expression of DR4 and DR5 before and after the CPT treatment.Conclusion:CPT combined with TRAIL may have a synergistic effect on induced apoptosis in PANC-1 cells.CPT down-regulates the expression of c-Flip protein,may possibly reverse the inhibition of caspase-8,and can activate the apoptotic signaling pathway.DR4 and DR5 do not play significant roles.

Triptolide sensitizes pancreatic cancer cells to TRAIL-induced activation of the death receptor pathway

In vitro synergistic cytotoxic effect of triptolide combined with hydroxycamptothecin on pancreatic cancer cells.

The Potential Molecular Mechanism of Overexpression of Upa, IL-8, MMP-7 and MMP-9 Induced by TRAIL in Pancreatic Cancer Cell.

Triptolide induces pancreatic cancer cell death via inhibition of heat shock protein 70

Triptolide Induces Apoptosis of Human Pancreatic Cancer Cells

Triptolide Cooperates with Cisplatin to Induce Apoptosis in Gemcitabine-Resistant Pancreatic Cancer

Triptolide induces caspase-dependent cell death mediated via the mitochondrial pathway in leukemic cells

Triptolide Induces Apoptosis and Inhibits the Growth and Angiogenesis of Human Pancreatic Cancer Cells by Downregulating COX-2 and VEGF.

Combined Strategies Of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand And Small Molecular Drugs To Inhibit Pancreatic Cancer Cell Proliferation And Tumor Growth

Triptolide induces apoptosis through the calcium/calmodulin‑dependent protein kinase kinaseβ/AMP‑activated protein kinase signaling pathway in non‑small cell lung cancer cells.

Research on TRAIL Combined with Camptothecin in Inducing Apoptosis of Pancreatic Carcinoma Cell Line PANC-1

Triptolide Enhances the Sensitivity of Pancreatic Cancer PANC-1 Cells to Gemcitabine by Inhibiting TLR4/NF-κB Signaling.

Mechanisms of cancer cell death induction by triptolide

Paclitaxel Enhances Tumoricidal Potential of TRAIL Via Inhibition of MAPK in Resistant Gastric Cancer Cells.

Ipatasertib Sensitizes Colon Cancer Cells to TRAIL-induced Apoptosis Through ROS-mediated Caspase Activation.

Triptolide sensitizes cisplatin-resistant human epithelial ovarian cancer by inhibiting the phosphorylation of AKT.

Novel Insights into the Synergistic Interaction of a Thioredoxin Reductase Inhibitor and TRAIL: the Activation of the ASK1-ERK-Sp1 Pathway

Synergistic Antitumor Activity of Gemcitabine Combined with Triptolide in Pancreatic Cancer Cells.

Triptolide Induces Apoptosis and Autophagy in Cutaneous Squamous Cell Carcinoma <i>via</i> Akt/mTOR Pathway

The Effects of Triptolide on the Proliferation and Apoptosis of Pancreatic Cancer Cell

Vitamin E Δ-Tocotrienol Sensitizes Human Pancreatic Cancer Cells to TRAIL-induced Apoptosis Through Proteasome-Mediated Down-Regulation of C-Flips